COVID-19 AMA: J&J Says Its Vaccine Is Effective Against Delta Variant, WHO Says All Authorized Vaccines Should Be Recognized By The West And More
Description
Detail of boxes with the U.S. donated Johnson & Johnson vaccine against Covid-19 at Universidad de Baja California on June 17, 2021 in Tijuana, Baja California. ; Credit: Francisco Vega/Getty Images
James Chow | AirTalk
In our continuing series looking at the latest medical research and news on COVID-19, Larry Mantle speaks with Dr. Annabelle De St. Maurice from University of California Los Angeles/Mattel Children’s hospital.
Topics today include:
J&J says its vaccine is effective against Delta variant
J&J vaccine lasts at least 8 months
WHO says all vaccines it authorized should be recognized by reopening countries
White House says it will miss July 4 vaccination goal
Postpartum depression on the rise during the pandemic
Experts believe Novavax may play a role in combating vaccine hesitancy
Delta variant is not driving a surge in hospitalization rates in England
Guest:
Annabelle De St. Maurice, M.D., assistant professor of pediatrics in the division of infectious diseases and the co-chief infection prevention officer at University of California Los Angeles/Mattel Children’s hospital; she tweets @destmauricemd
This content is from Southern California Public Radio. View the original story at SCPR.org.
United States
